Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 20-F/A Annual report (foreign)
- 2.1 Description of Securities
- 4.84 Extension of Debenture Maturity
- 4.85 Extension of Debenture Maturity
- 4.86 Extension of Debenture Maturity
- 4.87 License and Supply Agreement
- 4.88 Promissory Note
- 4.89 Promissory Note Extension
- 8.1 List of Subsidiaries
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent
- Download Excel data file
- View Excel data file
IPCIF similar filings
Filing view
External links
EXHIBIT 4.85
Extension of Debenture Maturity Date
TO Intellipharmaceutics International Inc. (the "Company")
RE: Debenture dated September 10, 2018 with an original face amount of US$500,000 issued by the Company to Dr. Isa Odidi and Dr. Amina Odidi (the "Debenture") and the Maturity Date (as defined in the Debenture) of such Debenture
|
The undersigned hereby agree that the Maturity Date of the Debenture (currently May 31, 2022) is extended to November 30, 2022.
DATED effective May 31, 2022.
/s/ Isa Odidi | /s/ Amina Odidi | |||
Isa Odidi | Amina Odidi |